Antibody drug conjugates (ADCs) mark a new era in targeted cancer therapy, delivering potent cytotoxic chemotherapy via monoclonal antibodies directly into the tumor cells — an era with potentially ...
Antibody-drug conjugates are receiving unrivaled attention across the biopharma sector. Fueled by Enhertu’s tumor-agnostic accelerated approval, practice changing combination results from Seagen and ...
After five years of unprecedented momentum, the ADC field now finds itself at an interesting inflection point. With more programs in development and greater industry prioritization than ever before, ...
Daiichi Sankyo and Merck & Co.’s phase 3 program for their investigational antibody-drug conjugate has been hit with a hold after an unexpected number of deaths were reported in the global trial. “Due ...
Andrew Bloomenthal has 20+ years of editorial experience as a financial journalist and as a financial services marketing writer. David Kindness is a Certified Public Accountant (CPA) and an expert in ...
Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...
Abstract: High-resolution ADCs require low noise and low distortion while consuming minimal power. This paper presents a power-efficient, calibration-free, 2nd-order ...
Abstract: The resolution of SAR ADCs is primarily limited by sampling noise, DAC mismatch, and comparator noise. This work presents a noise-shaping SAR ADC design ...
ADC is a command line utility that interfaces with API7 Enterprise and Apache APISIX Admin APIs. You can configure ADC through environment variables or command line flags. Run adc help [command] to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback